Effects of Lifestyle Changes to Reduce Risks of Diabetes and Associated Cardiovascular Risks: Results from Large Scale Efficacy Trials
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The increasing prevalence of type 2 diabetes throughout the world is now recognized as a major health problem. A growing segment of the population has impaired glucose tolerance (IGT), which is a strong predictor of progression to type 2 diabetes. Further, 24% of Americans now meet the criteria for the metabolic syndrome, a risk factor for both type 2 diabetes and cardiovascular disease (CVD). The diabetes epidemic is associated with changes in lifestyle—most notably increased energy intake, changes in diet composition and decreased levels of physical activity—and the development of overweight and obesity. This review examines the effects of several intensive lifestyle intervention trials on the risk of diabetes and CVD among high‐risk populations. Common features of these lifestyle interventions are dietary modification, weight loss and increased physical activity. These trials indicate that lifestyle modification is effective in decreasing the progression from IGT to type 2 diabetes and reducing CVD risk factors. However, the effectiveness of lifestyle interventions for reductions in CVD events has yet to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Weight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 1×
“In the progression from normal glucose metabolism to type 2 diabetes there is a progressive loss of glucose stimulated insulin secretion, particularly the rapid, first phase insulin secretion, in response to oral or intravenous glucose administration (9).”
BackgroundU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Cited by
Schellenberg, E. S., Dryden, D. M., Vandermeer, B., Ha, C., & Korownyk, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-8-201310150-00007 · Cited by 520
Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., Takasu, T., Imamura, M., Li, Q., Tomiyama, H., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.014 · Cited by 310
Supervised walking therapy in patients with intermittent claudication
Fakhry, F., van de Luijtgaarden, K. M., Bax, L., den Hoed, P. T., Hunink, M. G. M., Rouwet, E. V., & Spronk, S. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.04.046 · Cited by 172
Greenlee, H. A., Crew, K. D., Mata, J. M., McKinley, P. S., Rundle, A. G., Zhang, W., Liao, Y., Tsai, W. Y., & Hershman, D. L. (2013) · Obesity · doi:10.1002/oby.20245 · Cited by 111
Coker, R. H., Miller, S., Schutzler, S., Deutz, N., & Wolfe, R. R. (2012) · Nutrition Journal · doi:10.1186/1475-2891-11-105 · Cited by 92
“In addition, supplementation of high quality protein twice a day promoted an increase in lean body mass, strength and functional capacity in elderly volunteers with concomitant changes in diet or activity [15].”
BackgroundMethodLakerveld, J., Bot, S. D., Chinapaw, M. J., van Tulder, M. W., Kostense, P. J., Dekker, J. M., & Nijpels, G. (2013) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-10-47 · Cited by 84
Lee, C. D., Chae, J., Schap, T. E., Kerr, D. A., Delp, E. J., Ebert, D. S., & Boushey, C. J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600231 · Cited by 58
Molecular Regulators of Exercise-mediated Insulin Sensitivity in Non-obese Individuals
Almuraikhy, S., Doudin, A., Domling, A., Althani, A. A. J. F., & Elrayess, M. A. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18015 · Cited by 16
“7 7–9 Other positive health outcomes include improved insulin sensitivity and reduced risk of T2D.”
Background
Metadata
- Authors
- Horton, E. S.
- Venue
- Obesity
- Publisher
- Wiley
- Published
- 2009-12
- Volume
- 17
- Issue
- S3
- Pages
- S43-8
- ISSN
- 1930-7381 (ISSN-L)
- 1930-739X
- OpenAlex
- W1972011038
- Cited by
- 111
- References
- 27
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.